CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

CD26, a 110-kDa transmembrane glycoprotein that is expressed on several tumor cells including malignant lymphoma, has been implicated in tumorigenesis: however, little is known regarding its role in multiple myeloma (MM). Recently, we identified CD26 expression on human osteoclasts (OCs) and demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Hiroko, Hayashi, Mutsumi, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197267/
https://www.ncbi.nlm.nih.gov/pubmed/30348967
http://dx.doi.org/10.1038/s41408-018-0127-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197267/
https://www.ncbi.nlm.nih.gov/pubmed/30348967
http://dx.doi.org/10.1038/s41408-018-0127-y

Ejemplares similares